Related references
Note: Only part of the references are listed.Agomelatine for Depression in Parkinson Disease Additional Effect on Sleep and Motor Dysfunction
Asuncion Avila et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Safety and Tolerability of Agomelatine: Focus on Hepatotoxicity
Maximilian Gahr et al.
CURRENT DRUG METABOLISM (2014)
Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials
Kai-Lin Huang et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014)
Comparable efficacy and safety of 8 weeks treatment with agomelatine 25-50 mg or fluoxetine 20-40 mg in Asian out-patients with major depressive disorder
L. Shu et al.
ASIAN JOURNAL OF PSYCHIATRY (2014)
A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline
Koen Demyttenaere et al.
CNS SPECTRUMS (2013)
Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control
Siegfried Kasper et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2013)
Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial
Emmanuelle Corruble et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
The Efficacy of Agomelatine in Elderly Patients With Recurrent Major Depressive Disorder: A Placebo-Controlled Study
Reinhard Heun et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Agomelatine versus other antidepressive agents for major depression
Giuseppe Guaiana et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder A Pilot Study
Giovanni Martinotti et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients
Maria-Antonia Quera-Salva et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2011)
Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients
Maria-Antonia Quera-Salva et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study
Anthony Hale et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
Agomelatine in the Treatment of Major Depressive Disorder: An 8-Week, Multicenter, Randomized, Placebo-Controlled Trial
Stephen M. Stahl et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
The antidepressant agomelatine improves the quality of life of depressed patients: implications for remission
Pierre-Michel Llorca
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Clinical Studies on the Efficacy of Agomelatine on Depressive Symptoms
Guy M. Goodwin
CNS DRUGS (2009)
Agomelatine Prevents Relapse in Patients With Major Depressive Disorder Without Evidence of a Discontinuation Syndrome: A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial
Guy M. Goodwin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR
Sidney H. Kennedy et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: Randomized, double-blind comparison with venlafaxine
Patrick Lemoine et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Share Paper
